PT  - JOURNAL ARTICLE
AU  - Samantha J. Zwiebel
AU  - Adele C. Viguera
TI  - Discontinuing antidepressants: Pearls and pitfalls
AID  - 10.3949/ccjm.89a.21020
DP  - 2022 Jan 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 18--26
VI  - 89
IP  - 1
4099  - http://www.ccjm.org/content/89/1/18.short
4100  - http://www.ccjm.org/content/89/1/18.full
SO  - Cleve Clin J Med2022 Jan 01; 89
AB  - Stopping antidepressants can be challenging due to the high rate of discontinuation symptoms. Patients with antidepressant discontinuation syndrome (ADS) commonly experience insomnia, flu-like symptoms, mood disturbances, dizziness, and paresthesias, but a broad array of adverse effects is possible. Symptoms can last for days to months, and different symptoms have different durations. Patient education, identification of patients most at risk for developing symptoms, and a slow antidepressant taper or cross-taper are important steps in mitigating the risk of ADS and managing patient concerns about ADS. Tapers should be carried out over weeks to months. Discontinuation symptoms should be managed with restarting the prior dose of antidepressant and then tapering even more slowly, with additional symptomatic management as needed.